After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
These under-$10 stocks look ready to break out and trade higher from current levels.
Immediate public backlash on social media could end up being a more costly verdict for drugmakers' pricing powers.
MannKind (MNKD) is set to report 2016 second quarter results after Monday's market close.
MannKind (MNKD) stock is plummeting in late-morning trading on Tuesday after reporting 2016 first quarter results.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.